A Revised Staging System for Waldenstr öm's Macroglobulinemia

A significant proportion of patients with Waldenstr öm's Macroglobulinemia (WM) can survive for more than 10 years, but some patients die early during the course of the disease.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Maria Gavriatopoulou, Efstathios Kastritis, Marie Christine Kyrtsonis, Evdoxia Hatjiharissi, Eirini Katodritou, Panagiotis Repousis, Argiris Symeonidis, Michalis Michael, Anastasia Pouli, Nikolaos Giannakoulas, Dimitrios Christoulas, Aikaterini Megalakaki Source Type: research